DYFIXA
Therapeutic Segment: Antibiotic
Generic Name: Rifaximin
200mg dose is indicated for the treatment of patients (> 12 years of age) with traveler’s diarrhea caused by noninvasive strains of Escherichia coli.
550mg dose is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age.
550mg dose is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients 18 years of age.
Available as: 
PRESCRIBING INFORMATION
Tablets
- 200 MG